Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like GlaxoSmithKline Ditches Ionis Pharma's Inotersen and IONIS-FB-LRx August 10, 2017 Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials July 18, 2017 3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon September 21, 2017
